Insiders Immunovia AB

Equities

Delayed Nasdaq Stockholm Other stock markets 10:33:23 28/06/2024 BST			5-day change	1st Jan Change
1.602 ^SEK	-0.25%		-16.39%	-9.59%

05-21	Immunovia Seeks SEK70 Million from Proposed Rights Offering	MT
04-29	Transcript : Immunovia AB, Q1 2024 Earnings Call, Apr 29, 2024

Immunovia Appoints Lisa Ford as Clinical Laboratory Director	04-29	CI
Immunovia AB Elects Melissa Farina and Valerie Bogdan-Powers as New Board Members	11-21	CI
Immunovia AB Announces Board Appointments	03/10/23	CI
Immunovia AB Announces Board Changes	26/05/23	CI
Immunovia AB Announces Board Changes	22/05/23	CI
Philipp Von Hugo Resigns from Immunovia's Board at His Own Request	06/05/23	CI
Immunovia Names US Head as New Global CEO	02/05/23	MT
Immunovia AB Appoints New CEO	29/04/23	CI
Immunovia AB Announces Decline of Re-Election of Board of Directors	25/04/23	CI
Swedish Diagnostics Group Immunovia Appoints COO	01/03/23	MT
Immunovia Appoints Karl Stone as New Chief Operating Officer to Develop R&D and Operations	01/03/23	CI
Immunovia AB Appoints Lara E. Sucheston-Campbell as the Head of Clinical and Medical Affairs, Effective February 1, 2023	17/01/23	CI
Immunovia Inc. Appoints Jon Hager as New National Sales Director	05/12/22	CI
Immunovia AB Announces Appointment of Nomination Committee for the 2023 Annual General Meeting	20/10/22	CI
Sweden's Immunovia to Hire COO in Q1 2023	19/10/22	MT
Immunovia AB Announces Executive Management Team Appointments	19/10/22	CI
Immunovia Makes Acting President/CEO Permanent	02/06/22	MT
Immunovia AB Announces Executive Changes	02/06/22	CI
Immunovia Names Philipp Mathieu as Chief Executive Officer	02/06/22	CI
Immunovia AB Appoints Natalie Carfora as Head of Market Access US Subsidiary	16/05/22	CI

No results for this search